Adjuvant endocrine therapy in breast cancer
Journal Title: Współczesna Onkologia - Year 2007, Vol 11, Issue 2
Abstract
Endocrine therapy is the most important component of adjuvant therapy for patients with hormone receptor-positive breast cancer, regardless of age and menopausal status. Tamoxifen improves survival in premenopausal and postmenopausal women. In premenopausal patients it is used alone, in combination with ovarian suppression, or sequentially, after chemotherapy. Ovarian ablation/suppression in the absence of chemotherapy significantly improves survival in patients younger than 50. Combined with tamoxifen it offers an outcome similar to that of CMF chemotherapy. There is no clear benefit from adding ovarian ablation/suppression after chemotherapy. Aromatase inhibitors are now considered an integral part of endocrine therapy in postmenopausal women. They can be given as initial adjuvant treatment, sequentially with tamoxifen or as extended therapy after tamoxifen. However, neither the optimal duration nor sequencing nor long-term safety of aromatase inhibitors is known. They should not be given in premenopausal women otherwise than in clinical trials.
Authors and Affiliations
Anna Niwińska, Maria Litwiniuk
Keywords
Related Articles
- EP ID EP133931
- DOI -
- Views 51
- Downloads 0
Matrix metalloproteinases - biochemical characteristics and clinical value determination in breast cancer patiets
The matrix metalloproteinases (MMPs) constitute a group of zinc-dependent endopeptidases, which primary function is remodelling of components in the extracellular matrix. These enzymes are synthetized in cells, and secre...
Ocena wpływu leczenia anemii erytropoetyną na efektywność planowanej chemioterapii u chorych na nowotwory złośliwe na podstawie danych klinicznych i wybranych parametrów
Anemia jest często występującym powikłaniem u chorych na nowotwory. Może ona być wyłącznie następstwem obecności nowotworu (tzw. anemia towarzysząca nowotworom – cancer-related anemia – CRA) lub rozwijać się pod wpływe...
Centralny ziarniniak olbrzymiokomórkowy żuchwy o różnym przebiegu klinicznym – przegląd piśmiennictwa i własne obserwacje
Centralny ziarniniak olbrzymiokomórkowy (Central Giant Cell Granuloma, CGCG) należy – wg klasyfikacji WHO – do zmian guzopodobnych. Jest to rzadko występująca zmiana odczynowa w obrębie części twarzowej czaszki (7%), z...
A comparison of NMR scan to transrectal ultrasound - measured prostate volume in untreated prostate cancer
Purpose: Prostate cancer is one of the most common malignancies in men in developed European countries. Disease confined to the prostate gland can be definitively treated with radical radiation therapy. There are some...
Effectiveness of anterior resection with total mesorectal excision in curative treatment for rectal carcinoma in males
Aim: Aim of the study was to evaluate the effectiveness of anterior resection with total mesorectal excision (TME) in surgical management for rectal cancer in male patients, for whom the achievement of adequate radial re...